Even in clinically normal elderly, there is evidence that APOE genotype affects likelihood of cognitive decline [14–16], and affects brain structure and function as measured by structural [17–19] and functional [20–25] neuroimaging, and neuropathology [26]. The gene discussed is APOE; the disease is Mental deterioration.